De novo protein binders
Designed to bind.
Built to heal.
De novo protein binders, engineered for Alzheimer’s disease — and the targets that matter most.
Design, not discovery
Most medicines are discovered. We design ours.
Bindlix is building multifunctional AI-designed binders that solve brain delivery challenges and unlock a new generation of Alzheimer’s therapeutics — engineered to recognise a single disease-relevant shape, then validated in the lab.
- 01
Platform
A computational cascade that designs, counter-screens, and ranks binders before a single experiment.
- 02
Pipeline
A lead discovery program targeting the toxic protein species of Alzheimer’s disease.
- 03
Team
Protein designers and structural biologists building binders the way engineers build machines.